SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole
Status:
Withdrawn
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how safe, effective, and well tolerated a new
investigational antifungal drug, SUBA-itraconazole, is for patients who have been previously
treated with fluconazole and have had either an insufficient response to treatment with
fluconazole or a negative reaction to fluconazole preventing their further treatment with it.